About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Pennsylvania | 498 Studies

Clinical Trials Colorectal CancerPennsylvania

Colorectal Cancer Clinical Trials in Pennsylvania

Find 498 clinical trials for colorectal cancer near Pennsylvania. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Pennsylvania

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 381-400 of 498 trials

CompletedA Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal CancerThis is an international multi-center, prospective, open-label, randomized, adaptive design phase 3 trial of the cancer stem cell pathway inhibitor napabucasin plus standard…NCT02753127·Birmingham, Alabama and 210 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedBevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard ChemotherapyRATIONALE: Bevacizumab may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell growth.NCT00066846·Anchorage, Alaska and 32 others

Active not recruitingFinancial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing TreatmentThis research trial studies the financial burden in patients with stage I-III colon or rectal cancer who are undergoing treatment.NCT03516942·Anchorage, Alaska and 715 others

Active not recruitingA Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815This phase 1 study will investigate the safety, dosing, and initial antitumor activity of JZP815 in participants with advanced or metastatic solid tumors harboring alterations in…NCT05557045·Los Angeles, California and 14 others

TerminatedEfficacy of Ginseng for Patients on RegorafenibThis is a randomized, multi-center phase II study of ginseng in colorectal cancer patients treated with regorafenib to determine if ginseng will reduce fatigue in this patient…NCT02581059·Indianapolis, Indiana and 4 others

WithdrawnSafety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal CancerThe FC-7 study is designed as an open label, single arm, Phase I/II dose-escalation study evaluating the combination of neratinib and cetuximab in patients with metastatic…NCT01960023·Gainesville, Florida and 11 others

CompletedPAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation StudyThis is a phase 3, randomized, double-blind, placebo-controlled multi-center study evaluating the efficacy of pegfilgrastim to reduce the incidence of febrile neutropenia (FN) in…NCT00911170·Muscle Shoals, Alabama and 153 others

CompletedUnderstanding Patient Preference on Colorectal Cancer Screening Options-PSUThere are significant barriers to colorectal cancer screening within underserved populations due to the cost, accessibility, and acceptability of screening methods.NCT06444542·Hershey, Pennsylvania

CompletedA Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic ServicesThe goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services.NCT02517554·Elkton, Maryland and 6 others

RecruitingCollecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome PatientsThis study collects blood and stool samples from patients with suspected or diagnosed Lynch syndrome to evaluate a deoxyribonucleic acid (DNA) screening technique for the…NCT05410977·Scottsdale, Arizona and 8 others

Active not recruitingEvaluation of the ctDNA LUNAR Test in an Average Patient Screening EpisodeThe ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization.NCT04136002·Anniston, Alabama and 270 others

Active not recruitingTesting the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesThis phase I trial investigates the best dose, possible benefits and/or side effects of BAY 1895344 in combination with FOLFIRI in treating patients with stomach or intestinal…NCT04535401·Duarte, California and 9 others

RecruitingA Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsThis is a Phase 1/2 open-label, multi-center, multi-national study with an initial dose escalation part to determine the recommended Phase II dose (RP2D) of MCLA-158 single agent…NCT03526835·La Jolla, California and 53 others

CompletedA Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.The purpose of this study is to assess the antitumor activity of ALIMTA plus Oxaliplatin combination therapy in patients with previously untreated advanced colorectal cancerNCT00034619·Huntsville, Alabama and 21 others

Active not recruitingA Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid TumorsThis is a Phase 1/2 study to assess the safety and efficacy of ELI-002 7P immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide \[Amph-CpG-7909\] plus a mixture of…NCT05726864·Gilbert, Arizona and 27 others

CompletedPhase 1 and 2 Study of PX-866 and CetuximabThe purpose of this Phase 1/2 open-label study is to determine the safety and efficacy of a cetuximab and PX-866 combination treatment.NCT01252628·Birmingham, Alabama and 39 others

CompletedIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsRATIONALE: Using BG00001 to insert the gene for interferon-beta into a person's pleural cavity may improve the body's ability to fight cancer.NCT00066404·Philadelphia, Pennsylvania

CompletedComparative Effectiveness of CTC & OCThe goal of this study is to compare the findings of virtual (CT-colonography) with findings of optical colonoscopies to determine if virtual colonoscopy is suitable for…NCT02143115·Chicago, Illinois and 4 others

CompletedMulti-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and CancerThe primary objective is to determine the sensitivity and specificity of the Exact Colorectal Cancer (CRC) screening test for colorectal cancer, using colonoscopy as the reference…NCT01397747·Birmingham, Alabama and 183 others

CompletedTo Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal CancerThe main purpose of this study is to find the best dose of hydroxychloroquine (HCQ) when given in combination with regorafenib and entinostat.NCT03215264·Philadelphia, Pennsylvania

PreviousPage 20 of 25Next

Other Conditions in Pennsylvania

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma